291 related articles for article (PubMed ID: 34185793)
1. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
Mpekoulis G; Frakolaki E; Taka S; Ioannidis A; Vassiliou AG; Kalliampakou KI; Patas K; Karakasiliotis I; Aidinis V; Chatzipanagiotou S; Angelakis E; Vassilacopoulou D; Vassilaki N
PLoS One; 2021; 16(6):e0253458. PubMed ID: 34185793
[TBL] [Abstract][Full Text] [Related]
2. Significance of Catecholamine Biosynthetic/Metabolic Pathway in SARS-CoV-2 Infection and COVID-19 Severity.
Mpekoulis G; Kalliampakou KI; Milona RS; Lagou D; Ioannidis A; Jahaj E; Chasapis CT; Kefallinos D; Karakasiliotis I; Kotanidou A; Chatzipanagiotou S; Vassilacopoulou D; Vassiliou AG; Angelakis E; Vassilaki N
Cells; 2022 Dec; 12(1):. PubMed ID: 36611805
[TBL] [Abstract][Full Text] [Related]
3. The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults.
Oliveto G; Scagnolari C; Frasca F; Sorrentino L; Matera L; Nenna R; Viscido A; Scordio M; Petrarca L; Maria Zicari A; Gentilini E; D'Ettorre G; Ceccarelli G; Midulla F; Antonelli G; Pierangeli A
Cytokine; 2022 Oct; 158():155997. PubMed ID: 35969900
[TBL] [Abstract][Full Text] [Related]
4. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
5. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
6. Regulation of IFNα-induced expression of the short ACE2 isoform by ULK1.
Perez RE; Saleiro D; Ilut L; Schiltz GE; Eckerdt F; Fish EN; Platanias LC
Mol Immunol; 2022 Jul; 147():1-9. PubMed ID: 35489289
[TBL] [Abstract][Full Text] [Related]
7. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites.
Williams TL; Strachan G; Macrae RGC; Kuc RE; Nyimanu D; Paterson AL; Sinha S; Maguire JJ; Davenport AP
Sci Rep; 2021 Dec; 11(1):24336. PubMed ID: 34934117
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
[TBL] [Abstract][Full Text] [Related]
9. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
Onabajo OO; Banday AR; Stanifer ML; Yan W; Obajemu A; Santer DM; Florez-Vargas O; Piontkivska H; Vargas JM; Ring TJ; Kee C; Doldan P; Tyrrell DL; Mendoza JL; Boulant S; Prokunina-Olsson L
Nat Genet; 2020 Dec; 52(12):1283-1293. PubMed ID: 33077916
[TBL] [Abstract][Full Text] [Related]
10. Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2.
Onabajo OO; Banday AR; Yan W; Obajemu A; Stanifer ML; Santer DM; Florez-Vargas O; Piontkivska H; Vargas J; Kee C; Tyrrell DLJ; Mendoza JL; Boulant S; Prokunina-Olsson L
bioRxiv; 2020 Jul; ():. PubMed ID: 32743577
[TBL] [Abstract][Full Text] [Related]
11. Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis.
Nataf S; Pays L
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638785
[TBL] [Abstract][Full Text] [Related]
12. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress.
Rossi ÁD; de Araújo JLF; de Almeida TB; Ribeiro-Alves M; de Almeida Velozo C; Almeida JM; de Carvalho Leitão I; Ferreira SN; da Silva Oliveira J; Alves HJ; Scheid HT; Faffe DS; Galliez RM; de Ávila RE; Resende GG; Teixeira MM; ; da Costa Ferreira Júnior O; Castiñeiras TMPP; Souza RP; Tanuri A; Aguiar RS; Barroso SPC; Cardoso CC
Sci Rep; 2021 May; 11(1):9658. PubMed ID: 33958627
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients.
Gutiérrez-Chamorro L; Riveira-Muñoz E; Barrios C; Palau V; Nevot M; Pedreño-López S; Senserrich J; Massanella M; Clotet B; Cabrera C; Mitjà O; Crespo M; Pascual J; Riera M; Ballana E
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578296
[TBL] [Abstract][Full Text] [Related]
14. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
Scagnolari C; Bitossi C; Viscido A; Frasca F; Oliveto G; Scordio M; Petrarca L; Mancino E; Nenna R; Riva E; De Vito C; Midulla F; Antonelli G; Pierangeli A
Cytokine; 2021 Apr; 140():155430. PubMed ID: 33508651
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
16. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
[TBL] [Abstract][Full Text] [Related]
17. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
Zhou Y; Wang M; Li Y; Wang P; Zhao P; Yang Z; Wang S; Zhang L; Li Z; Jia K; Zhong C; Li N; Yu Y; Hou J
Immunol Lett; 2021 Sep; 237():33-41. PubMed ID: 34228987
[TBL] [Abstract][Full Text] [Related]
19. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.
Blume C; Jackson CL; Spalluto CM; Legebeke J; Nazlamova L; Conforti F; Perotin JM; Frank M; Butler J; Crispin M; Coles J; Thompson J; Ridley RA; Dean LSN; Loxham M; Reikine S; Azim A; Tariq K; Johnston DA; Skipp PJ; Djukanovic R; Baralle D; McCormick CJ; Davies DE; Lucas JS; Wheway G; Mennella V
Nat Genet; 2021 Feb; 53(2):205-214. PubMed ID: 33432184
[TBL] [Abstract][Full Text] [Related]
20. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
